¶ Alzheimer's Disease Nutraceutical and Dietary Supplement Companies
This page catalogs companies developing nutraceuticals, dietary supplements, and brain health products targeting Alzheimer's disease and cognitive decline. These products range from single-ingredient supplements to complex formulations, including nootropics, medical foods, and nutritional interventions.
| Category |
Description |
Examples |
| Cognitive Enhancers |
Supplements for memory and focus |
Nootropics, choline sources |
| Neuroprotective |
Antioxidant and anti-inflammatory |
Curcumin, resveratrol, omega-3 |
| Medical Foods |
FDA-regulated nutritional products |
Axona, Cerefolin |
| Probiotic/Gut-Brain |
Microbiome-based supplements |
Probiotics, prebiotics |
| Vitamins/Minerals |
Essential nutrient supplementation |
B-vitamins, vitamin D, magnesium |
Focus: Premium supplements, cognitive support formulations
LifeExtension offers a range of brain health supplements including:
- CogniDHA (omega-3 DHA)
- Phosphatidylserine formulations
- B-vitamin complexes
- Curcumin/curcuminoid products
LifeExtension
Focus: Medical-grade supplements, precision nutrition
Thorne provides research-backed supplements including:
- Cognitive support formulations
- Methylation support (B-vitamins)
- Stress and sleep supplements
- Personalized supplement plans
Thorne
Focus: Large-scale supplement manufacturer
NOW Foods produces comprehensive brain health products:
- Omega-3 fish oils
- Ginkgo biloba extracts
- Acetyl-L-carnitine
- Phosphatidylcholine
- GABA formulations
NOW Foods
Focus: Professional-grade supplements
Pure Encapsulations offers cognitive support:
- Cognitive Complete (multi-ingredient)
- Curcumin formulations
- Vitamin D3 with K2
- Methylfolate supplements
Pure Encapsulations
Focus: Professional healthcare supplements
Douglas Laboratories provides:
- Cognitive support formulations
- Neuroprotective combinations
- Custom practitioner formulations
Douglas Laboratories
Focus: Medical nutrition, medical foods
Nutricia develops medical foods for cognitive decline:
- Souvenaid — Nutritional drink for early AD (Fortasem)
- Specialized formulations for mild cognitive impairment
- Research partnerships with academic institutions
Nutricia
Focus: Amino acids and nutrients
Kyowa Hakko produces key brain health ingredients:
- Cognizin — Proprietary citicoline
- Cognizin-based products in multiple formulations
- Licensed to multiple supplement manufacturers
Kyowa Hakko
| Company |
Key Ingredients |
Focus |
| Aurobindo |
Generic supplements |
Cost-effective |
| Stratum Nutrition |
Custom formulations |
Professional |
| Nutrient |
Bioavailable formats |
Absorption |
| capsaicin |
Capsaicin formulations |
Sensory processing |
| Product |
Company |
Key Ingredient |
Evidence Level |
| Cognizin Citicoline |
Kyowa Hakko |
Citicoline |
Multiple RCTs |
| Souvenaid/Nutricia |
Nutricia |
Fortasem |
Phase 3 trials |
| Axona |
Accera |
AC-1202 (MCT) |
FDA medical food |
| Cerefolin |
PBM |
L-methylfolate + B12 |
Clinical studies |
Axona (Accera):
- Medium-chain triglyceride (MCT) formula
- Indicated for management of mild to moderate AD
- Provides alternative brain fuel (ketones)
Cerefolin:
- L-methylfolate + B12 + B6
- Addresses methylation deficits in AD
Nootropics Depot
- Quality-controlled nootropic ingredients
- Lion's Mane, racetams, adaptogens
- Community and education focus
Nootropic Supplements (Generic)
- Focus formatted supplements
- Stack formulations
- Budget options
- Polyphenols: Curcumin, resveratrol, ECGC
- Omega-3s: EPA/DHA formulations, specialized oils
- Probiotics: Strain-specific formulations (Lactobacillus, Bifidobacterium)
- Vitamins: High-dose B-vitamins, vitamin D combinations
- Minerals: Magnesium threonate, zinc formulations
- Adaptogens: Rhodiola, ashwagandha, bacopa
¶ Clinical Trial Landscape
Most nutraceutical approaches show modest effects in:
- Mild cognitive impairment (MCI)
- Early Alzheimer's disease
- Prevention in at-risk populations
Limitations:
- Often underpowered studies
- Heterogeneous formulations
- Limited regulatory oversight
- Third-party testing — USP, NSF, ConsumerLab
- Bioavailability — Enhanced absorption formats
- Clinical evidence — Published human studies
- Manufacturing standards — GMP, FDA registration
- Ingredient transparency — Full disclosure
- Proprietary blends without dosages
- Unrealistic claims
- No third-party testing
- No contact information
¶ Regulatory Landscape
| Category |
FDA Oversight |
Requirements |
| Dietary Supplement |
Low |
DSHEA, label claims |
| Medical Food |
High |
Prescription-like, clinical evidence |
| Medical Device |
Medium |
510(k) or PMA |
| Drug |
Highest |
Full approval process |
- Structure/Function: "Supports brain health"
- Nutrient deficiency: "Contains vitamin D"
- Medical Food: Must address specific disease